Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Neuroblastoma 2

Interventions

Specimen Handling 195Magnetic Resonance Spectroscopy 148Biopsy 119pembrolizumab 90Carboplatin 81Cisplatin 74Nivolumab 72Cyclophosphamide 65Paclitaxel 61Gemcitabine 49Radiotherapy 47Bevacizumab 43Dexamethasone 39durvalumab 36venetoclax 34Fluorouracil 34atezolizumab 33Pemetrexed 32Injections 32Capecitabine 32Doxorubicin 31olaparib 30Rituximab 30Radiation 28Oxaliplatin 28Lenalidomide 28Prednisone 27Etoposide 27fludarabine 26X-Rays 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × saponin QA-21V1 × 30 days × Clear all
NCT06057948 2026-06-05

A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
94 enrolled
CNS

Neuroblastoma

NCT04936529 2026-05-07

A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
286 enrolled
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡